BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29670079)

  • 1. Upregulation of neuronal astrocyte elevated gene-1 protects nigral dopaminergic neurons in vivo.
    Leem E; Kim HJ; Choi M; Kim S; Oh YS; Lee KJ; Choe YS; Um JY; Shin WH; Jeong JY; Jin BK; Kim DW; McLean C; Fisher PB; Kholodilov N; Ahn KS; Lee JM; Jung UJ; Lee SG; Kim SR
    Cell Death Dis; 2018 May; 9(5):449. PubMed ID: 29670079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of nigral dopaminergic neurons by AAV1 transduction with Rheb(S16H) against neurotoxic inflammation in vivo.
    Kim S; Moon GJ; Oh YS; Park J; Shin WH; Jeong JY; Choi KS; Jin BK; Kholodilov N; Burke RE; Kim HJ; Ha CM; Lee SG; Kim SR
    Exp Mol Med; 2018 Feb; 50(2):e440. PubMed ID: 29422542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activin A protects midbrain neurons in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Stayte S; Rentsch P; Li KM; Vissel B
    PLoS One; 2015; 10(4):e0124325. PubMed ID: 25902062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease.
    Cunningham LA; Su C
    Exp Neurol; 2002 Apr; 174(2):230-42. PubMed ID: 11922664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CX3CR1 Disruption Differentially Influences Dopaminergic Neuron Degeneration in Parkinsonian Mice Depending on the Neurotoxin and Route of Administration.
    Tristão FS; Lazzarini M; Martin S; Amar M; Stühmer W; Kirchhoff F; Gomes LA; Lanfumey L; Prediger RD; Sepulveda JE; Del-Bel EA; Raisman-Vozari R
    Neurotox Res; 2016 Apr; 29(3):364-80. PubMed ID: 26403659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged Dysfunction of Astrocytes and Activation of Microglia Accelerate Degeneration of Dopaminergic Neurons in the Rat Substantia Nigra and Block Compensation of Early Motor Dysfunction Induced by 6-OHDA.
    Kuter K; Olech Ł; Głowacka U
    Mol Neurobiol; 2018 Apr; 55(4):3049-3066. PubMed ID: 28466266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Kv7/KCNQ channel blocker XE991 protects nigral dopaminergic neurons in the 6-hydroxydopamine rat model of Parkinson's disease.
    Liu H; Jia L; Chen X; Shi L; Xie J
    Brain Res Bull; 2018 Mar; 137():132-139. PubMed ID: 29174294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD2 promotes dopaminergic degeneration regulated by NADPH oxidase 2 in 6-hydroxydopamine model of Parkinson's disease.
    Cheng L; Chen L; Wei X; Wang Y; Ren Z; Zeng S; Zhang X; Wen H; Gao C; Liu H
    J Neuroinflammation; 2018 Aug; 15(1):243. PubMed ID: 30157869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF.
    Nam JH; Park ES; Won SY; Lee YA; Kim KI; Jeong JY; Baek JY; Cho EJ; Jin M; Chung YC; Lee BD; Kim SH; Kim EG; Byun K; Lee B; Woo DH; Lee CJ; Kim SR; Bok E; Kim YS; Ahn TB; Ko HW; Brahmachari S; Pletinkova O; Troconso JC; Dawson VL; Dawson TM; Jin BK
    Brain; 2015 Dec; 138(Pt 12):3610-22. PubMed ID: 26490328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin protects nigral dopaminergic neurons by iron-chelation in the 6-hydroxydopamine rat model of Parkinson's disease.
    Du XX; Xu HM; Jiang H; Song N; Wang J; Xie JX
    Neurosci Bull; 2012 Jun; 28(3):253-8. PubMed ID: 22622825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mfn2 protects dopaminergic neurons exposed to paraquat both in vitro and in vivo: Implications for idiopathic Parkinson's disease.
    Zhao F; Wang W; Wang C; Siedlak SL; Fujioka H; Tang B; Zhu X
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1359-1370. PubMed ID: 28215578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted deletion of the aquaglyceroporin AQP9 is protective in a mouse model of Parkinson's disease.
    Stahl K; Rahmani S; Prydz A; Skauli N; MacAulay N; Mylonakou MN; Torp R; Skare Ø; Berg T; Leergaard TB; Paulsen RE; Ottersen OP; Amiry-Moghaddam M
    PLoS One; 2018; 13(3):e0194896. PubMed ID: 29566083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-OHDA Induces Oxidation of F-box Protein Fbw7β by Chaperone-Mediated Autophagy in Parkinson's Model.
    Wang X; Zhai H; Wang F
    Mol Neurobiol; 2018 Jun; 55(6):4825-4833. PubMed ID: 28733899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myricitrin Ameliorates 6-Hydroxydopamine-Induced Dopaminergic Neuronal Loss in the Substantia Nigra of Mouse Brain.
    Kim HD; Jeong KH; Jung UJ; Kim SR
    J Med Food; 2016 Apr; 19(4):374-82. PubMed ID: 26991235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Zn
    Tamano H; Nishio R; Morioka H; Takeda A
    Mol Neurobiol; 2019 Jan; 56(1):435-443. PubMed ID: 29705946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of GDNF and BDNF by hRheb(S16H) transduction of SNpc neurons: neuroprotective mechanisms of hRheb(S16H) in a model of Parkinson's disease.
    Nam JH; Leem E; Jeon MT; Jeong KH; Park JW; Jung UJ; Kholodilov N; Burke RE; Jin BK; Kim SR
    Mol Neurobiol; 2015 Apr; 51(2):487-99. PubMed ID: 24859383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of lentivirus-mediated cystathionine-beta-synthase overexpression against 6-OHDA-induced parkinson's disease rats.
    Yin WL; Yin WG; Huang BS; Wu LX
    Neurosci Lett; 2017 Sep; 657():45-52. PubMed ID: 28764908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RING finger protein 11 (RNF11) modulates susceptibility to 6-OHDA-induced nigral degeneration and behavioral deficits through NF-κB signaling in dopaminergic cells.
    Pranski EL; Dalal NV; Sanford CV; Herskowitz JH; Gearing M; Lazo C; Miller GW; Lah JJ; Levey AI; Betarbet RS
    Neurobiol Dis; 2013 Jun; 54():264-79. PubMed ID: 23318928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of Nrf2-ARE activator on dopaminergic neuronal loss in Parkinson disease model mice: Possible involvement of heme oxygenase-1.
    Inose Y; Izumi Y; Takada-Takatori Y; Akaike A; Koyama Y; Kaneko S; Kume T
    Neurosci Lett; 2020 Sep; 736():135268. PubMed ID: 32712353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic elimination of dopamine vesicular stocks in the nigrostriatal pathway replicates Parkinson's disease motor symptoms without neuronal degeneration in adult mice.
    Isingrini E; Guinaudie C; C Perret L; Rainer Q; Moquin L; Gratton A; Giros B
    Sci Rep; 2017 Sep; 7(1):12432. PubMed ID: 28963508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.